Detection of minimal residual disease by flow cytometry as a useful approach for predicting relapse in childhood B-lingeage acute lymphoblastic leukemia
ZHANG Fang,LI Ben-shang,WANG Xiang,MA Ya-ni,XUE Hui-liang,PAN Ci,YE Qi-dong,JIANG Hua,ZHOU Min,TANG Yan-jing,CHEN Jing
DOI: https://doi.org/10.3969/j.issn.1671-2870.2012.02.012
2012-01-01
Abstract:Objective To study the value of detection of minimal residual disease(MRD) by flow cytometry(FCM) during the process of chemotherapy for predicting relapse in childhood B-lingeage acute lymphoblastic leukemia.Methods MRD was detected by four-color flow cytometry on day 19,day 35,day 55(only for medium-or high-risk group) and week 13-17,week 28-36,week 52-54,week 78-83,week 102-107,last day of the chemotherapy process and during follow-up in 291 childhood B-lingeage acute lymphoblastic leukemia patients.Results ① MRD were <0.01%,0.01%-0.1%,0.1%-1%and >1% in 169,35,44,43 patients,respectively.The 7 years cumulative incidence of relapse were 4.1%,17.1%,29.5% and 62.8% in patients with MRD<0.01%,0.01%-0.1%,0.1%-1%and >1%,respectively.The differences between these four groups were statistically significant(P<0.0001).② The difference in relapse rate was statistically significant between MRD positive and MRD negative patients at every detection time point.(P=0.0021 on day 19,P=0.0008 on day 55,P=0.0025 during follow-up,and other time points P<0.0001) ③ Day 35 was an important time point to predict early and late relapse,week 14-17 was an important time point to predict early relapse,and MRD positive during follow-up was valuable for predicting late relapse.Conclusions MRD detection by flow cytometry is valuable for predicting relapse of childhood B-ALL and has different significance at different time points.